随着人口老龄化和经济的增长，我国生物医药行业发展向好。国家政策的加持为医药健康领域的投资发展指明了方向，在“十三五”规划中，中央提出的供给侧改革正在成为引领医药行业发展的新抓手。 据前瞻产业研究...
As the population ages and economic growth, improve biological medicine industry development in our country. The blessing of national policy pointed out the direction for development in the field of medicine and health investment, in "much starker choices-and graver consequences-in planning", the supply side of the central proposed reform is becoming a new gripper lead the development of the pharmaceutical industry. According to a prospective industry research...
